BBIO - BridgeBio Pharma raises $150M capital via stock offering
2023-03-08 07:08:52 ET
- BridgeBio Pharma ( NASDAQ: BBIO ) has priced its public offering of ~8.8M common shares at $17.00/share, for gross proceeds of ~$150M.
- Underwriters' over-allotment is an additional ~1.3M shares.
- Closing date is March 10.
- All of the shares in the offering to be sold by BridgeBio.
- Previously (March 6): BridgeBio Pharma announces $150M public offering
For further details see:
BridgeBio Pharma raises $150M capital via stock offering